On Friday, February 26, a panel of industry and medical-experts voted in favor of endorsing Johnson & Johnson’s COVID-19 vaccine, and recommending that the FDA approve its emergency use authorization, making it the third vaccine available in the United States in the ongoing battle against the pandemic.
Also on Friday, during his coronavirus response media-briefing, West Virginia Governor Jim Justice announced that the state “expects to receive an initial weekly allotment of approximately 15,000 doses of the new Johnson & Johnson COVID-19 vaccine” once the FDA has issued the authorization.
“If this comes to pass, next week our total doses in West Virginia should approach 60,000 between Johnson & Johnson, Moderna and Pfizer combined,” Justice said. “That’s great, great news and we’re ready for it.”
According to a statement released by Justice’s office, “The Johnson & Johnson vaccine requires only one shot, unlike the two-shot dosing for the vaccines from Pfizer and Moderna and it does not require special refrigeration for shipment and storage, making it particularly appealing for those in West Virginia’s rural areas.”
The West Virginia Daily News will provide updates regarding the potential FDA approval of the Johnson & Johnson COVID-19 vaccine, as well as the impact it may have on the Mountain State, as additional details are made available.